Updated:
Codon Capital
Investing in Series A biotech teams healing human and planetary health | Codon Capital is a San Francisco-based biotech venture capital company, specializing...
Overview
Investing in Series A biotech teams healing human and planetary health | Codon Capital is a San Francisco-based biotech venture capital company, specializing in therapeutics and synthetic biology. Our series A investment approach is to fund startup teams that can execute on difficult technical, definable achievements that enable breakthrough biotech products. We’re investing in solutions to the most critical problems of human health and sustainability, and in teams who can make the impossible possible.
General information
Firm type
Private Equity
Year founded
2013
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Codon Capital?
No named principals or investment committee members appear in available records.
Does Codon Capital participate in fund commitments or only direct deals?
Public sources do not disclose whether the firm makes fund commitments, direct investments or both.
What investment stages does Codon Capital typically target?
Listed strategies include early stage, seed, start-up and spin-offs.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: